Responses
Regular and young investigator award abstracts
Clinical trials in progress
374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
